Abstract:Human T lymphotropic virus 1 (HTLV-1) is a human retrovirus identified as the causative agent in adult T-cell leukemia/lymphoma (ATL) and chronic-progressive neuroinflammatory disorder HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). HTLV-1 is estimated to infect between 5-20 million people worldwide, although most infected individuals remain asymptomatic. HTLV-1 infected persons carry an estimated lifetime risk of approximately 5% of developing ATL, and between 0.25% and 1.8% of developing HAM/TSP. Most HTLV-1 infection is detected in CD4+ T cells in vivo which causes the aggressive malignancy in ATL. In HAM/TSP, the increase of HTLV-1 provirus induces immune dysregulation to alter inflammatory milieu, such as expansion of HTLV-1-specific CD8+ T cells, in the central nervous system of the infected subjects, which have been suggested to underlie the pathogenesis of HAM/TSP. Factors contributing to the conversion from asymptomatic carrier to disease state remain poorly understood. As such, the identification and tracking of HTLV-1-specific T cell biomarkers that may be used to monitor the progression from primary infection to immune dysfunction and disease are of great interest. T cell receptor (TCR) repertoires have been extensively investigated as a mechanism of monitoring adaptive T cell immune response to viruses and tumors. Breakthrough technologies such as single-cell RNA sequencing have increased the specificity with which T cell clones may be characterized and continue to improve our understanding of TCR signatures in viral infection, cancer, and associated treatments. In HTLV-1-associated disease, sequencing of TCR repertoires has been used to reveal repertoire patterns, diversity, and clonal expansions of HTLV-1-specific T cells capable of immune evasion and dysregulation in ATL as well as in HAM/TSP. Conserved sequence analysis has further been used to identify CDR3 motif sequences and exploit disease- or patient-specificity and commonality in HTLV-1-associated disease. In this article we review current research on TCR repertoires and HTLV-1-specific clonotypes in HTLV-1-associated diseases ATL and HAM/TSP and discuss the implications of TCR clonal expansions on HTLV-1-associated disease course and treatments.

Exploration of the Roles of HLAs When Predicting Infection Status by T Cell Receptors

High-sensitivity HLA typing by Saturated Tiling Capture Sequencing (STC-Seq)

Learning predictive signatures of HLA type from T-cell repertoires

Large-scale statistical mapping of T-cell receptor sequences to Human Leukocyte Antigens

Disease associated human TCR characterization by deep-learning framework TCR-DeepInsight

Analysis of the Repertoire Features of TCR Beta Chain CDR3 in Human by High-Throughput Sequencing

Detecting T-cell receptors involved in immune responses from single repertoire snapshots

Preselection TCR repertoire predicts CD4<SUP>+</SUP>and CD8<SUP>+</SUP>T-cell differentiation state

Study for complementarity determining region 3 of T cell receptor beta chain in infectious diseases

Predicting Antigen Specificity of Single T Cells Based on TCR CDR 3 Regions

Interpretable GWAS by linking clinical phenotypes to quantifiable immune repertoire components

Current Status and Recent Advances of Next Generation Sequencing Techniques in Immunological Repertoire

TCR-L: an analysis tool for evaluating the association between the T-cell receptor repertoire and clinical phenotypes

T cell receptor repertoire analysis in HTLV-1-associated diseases

Integrative HLA typing of tumor and adjacent normal tissue can reveal insights into the tumor immune response

Improved Deep Learning Prediction of TCR-HLA Association

Identifying immune signatures of common exposures through co-occurrence of T-cell receptors in tens of thousands of donors

The Pathogen Adaptation of HLA Alleles and the Correlation with Autoimmune Diseases based on the HLA Diversity Resource in the Han Chinese

Structural Basis of the TCR-pHLA Complex Provides Insights into the Unconventional Recognition of CDR3β in TCR Cross-Reactivity and Alloreactivity

Exploring the pre-immune landscape of antigen-specific T cells

In vitro and ex vivo functional characterization of human HLA-DRB1∗04 restricted T cell receptors